Clinical Trials Directory

Trials / Terminated

TerminatedNCT04436055

Intergenerational Effects of Paternal Periconceptional Cannabis and Other Drug Use (EPIC)

Status
Terminated
Phase
Study type
Observational
Enrollment
92 (actual)
Sponsor
Duke University · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The overall objective of this proposed project is to prospectively evaluate the epigenetic and developmental effects of paternal cannabis and other drug use in offspring.

Detailed description

This project involves enrollment of 40 healthy mother-father dyads that are between the ages of 18 and 40 years. Urine samples for qualitative drug and cotinine testing will be collected from mother-father dyads, as well as quantitative THC (tetrahydrocannabinol) and THCCOOH (11-nor-9-carboxy-THC) assay. A semen sample will be collected from biological fathers. Relevant birth outcome data including both infant and maternal measures will be extracted from the electronic health record (EHR). Infant developmental assessments will be completed at approximately 6 months of age.

Conditions

Interventions

TypeNameDescription
OTHERNo Intervention will be usedSince this is an observational study, there are no interventions.

Timeline

Start date
2020-10-26
Primary completion
2022-07-01
Completion
2022-07-01
First posted
2020-06-17
Last updated
2023-03-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04436055. Inclusion in this directory is not an endorsement.